The purpose of this FOA is to solicit applications proposing to test approaches for expanding medication assisted treatment (MAT) for opioid use disorder (OUD) in the general health care sector or linking individuals with OUDs who receive naloxone for the reversal of overdose to MAT in the context of states’ plans for use of the funds authorized under the 21st Century Cures Act.
Research topics may include but are not limited to the following:
  • OUD medications provided in emergency departments, pharmacies, inpatient units, and other health care settings.
  • Telehealth approaches for providing OUD medications in the general health care sector.
  • Models of care in the general health sector that provide a choice of OUD medications to patients.
  • Continuity of care models for those receiving medications for OUD. Models of care and delivery designed to expand the provision of OUD medications in primary care including, but not limited to the following:
    • The Massachusetts Nurse Care Manager Model.
    • The Hub and Spoke Model.
    • The Echo Model.
  • Other models described in the recent report, Chou R, Korthuis PT, Weimer M, Bougatsos C, Blazina I, Zakher B, Grusing S, Devine B, McCarty D. Medication-Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings. Technical Brief No. 28. (Prepared by the Pacific Northwest Evidence-based Practice Center under Contract No. 290-2015-00009-I.) AHRQ Publication No. 16(17)-EHC039-EF. Rockville, MD: Agency for Healthcare Research and Quality. December 2016. www.effectivehealthcare.ahrq.gov/reports/final.cfm.
  • Models of naloxone delivery that offer the opportunity for linkage to MAT after receipt of naloxone for overdose.
  • Interim methadone.
  • Interim buprenorphine.